Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBRA: Liraglutide for Beta-Cell Function in T2DM
NCT01270789Phase 3Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Jan 2011
- Primary completion
- Dec 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Mount Sinai Hospital. Started Jan 2011; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01270789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270789.